HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hwang, K.-K. Articles by Chen, P. P. Search for Related Content PubMed PubMed Citation Articles by Hwang, K.-K. Articles by Chen, P. P. Pubmed/NCBI databases Substance via MeSH

Identification of Anti-Thrombin Antibodies in the Antiphospholipid Syndrome That Interfere with the Inactivation of Thrombin by Antithrombin¹

Kwan-Ki Hwang^2,*, Jennifer M. Grossman^*, Sudha Visvanathan^*, Reginald U. Chukwuocha^*, Virgil L. Woods, Jr., Dzung T. Le, Bevra H. Hahn^* and Pojen P. Chen^*

^* Division of Rheumatology, Department of Medicine, University of California, Los Angeles, CA 90095; and Departments of Medicine and Pathology, University of California at San Diego, La Jolla, CA 92093

The combined presence of anti-phospholipid (PL) Ab, including lupus anticoagulants (LAC) and/or anticardiolipin Ab (aCL), and thrombosis is recognized as the antiphospholipid syndrome (APS). LAC are detected as an inhibitory effect on PL-restricted in vitro blood coagulation tests, and are comprised mainly of Ab against ₂ glycoprotein I and prothrombin (PT). Recently, anti-PT Ab (aPT) were found to be associated with thrombosis by some investigators, although this is not confirmed by others. Considering that aPT are heterogeneous in patients and that PT is converted into thrombin, we hypothesize that certain aPT in patients may bind to thrombin, and that some of such anti-thrombin Ab may interfere with thrombin-antithrombin (AT) interaction and thus reduce the AT inactivation of thrombin. To test this hypothesis, we searched for anti-thrombin Ab in APS patients and then studied those found for their effects on the AT inactivation of thrombin. The results revealed that most, but not all, aPT-positive patient plasma samples contained anti-thrombin Ab. To study the functional significance of these Ab, we identified six patient-derived mAb that bound to both PT and thrombin. Of these mAb, three could reduce the AT inactivation of thrombin, whereas others had minimal effect. These findings indicate that some aPT in patients react with thrombin, and that some of such anti-thrombin Ab could inhibit feedback regulation of thrombin. Because the latter anti-thrombin Ab are likely to promote clotting, it will be important to develop specific assays for such Ab and study their roles in thrombosis in APS patients.

This article has been cited by other articles:

				I. Giles, C. Pericleous, X. Liu, J. Ehsanullah, L. Clarke, P. Brogan, M. Newton-West, R. Swerlick, A. Lambrianides, P. Chen, et al. Thrombin Binding Predicts the Effects of Sequence Changes in a Human Monoclonal Antiphospholipid Antibody on Its In Vivo Biologic Actions J. Immunol., April 15, 2009; 182(8): 4836 - 4843. [Abstract] [Full Text] [PDF]

				Y.-H. Yang, D. Chien, M. Wu, J. FitzGerald, J. M. Grossman, B. H. Hahn, K.-K. Hwang, and P. P. Chen Novel Autoantibodies against the Activated Coagulation Factor IX (FIXa) in the Antiphospholipid Syndrome That Interpose the FIXa Regulation by Antithrombin J. Immunol., February 1, 2009; 182(3): 1674 - 1680. [Abstract] [Full Text] [PDF]

				P. Chen, C. Yang, K Ede, C. Wu, J. FitzGerald, and J. Grossman Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis Lupus, October 1, 2008; 17(10): 916 - 921. [Abstract] [PDF]

				X.-X. Chen, Y.-Y. Gu, S.-J. Li, J. Qian, K.-K. Hwang, P. P. Chen, S.-L. Chen, and C.-D. Yang Some Plasmin-Induced Antibodies Bind to Cardiolipin, Display Lupus Anticoagulant Activity and Induce Fetal Loss in Mice J. Immunol., April 15, 2007; 178(8): 5351 - 5356. [Abstract] [Full Text] [PDF]

				S. M. Abo and V. A. DeBari Laboratory Evaluation of the Antiphospholipid Syndrome Ann. Clin. Lab. Sci., January 1, 2007; 37(1): 3 - 14. [Abstract] [Full Text] [PDF]

				Y.-H. Yang, K.-K. Hwang, J. FitzGerald, J. M. Grossman, M. Taylor, B. H. Hahn, and P. P. Chen Antibodies against the Activated Coagulation Factor X (FXa) in the Antiphospholipid Syndrome That Interfere with the FXa Inactivation by Antithrombin J. Immunol., December 1, 2006; 177(11): 8219 - 8225. [Abstract] [Full Text] [PDF]

				I. Giles, N. Lambrianides, N. Pattni, D. Faulkes, D. Latchman, P. Chen, S. Pierangeli, D. Isenberg, and A. Rahman Arginine Residues Are Important in Determining the Binding of Human Monoclonal Antiphospholipid Antibodies to Clinically Relevant Antigens J. Immunol., August 1, 2006; 177(3): 1729 - 1736. [Abstract] [Full Text] [PDF]

				M L Bertolaccini and M A Khamashta Laboratory diagnosis and management challenges in the antiphospholipid syndrome Lupus, March 1, 2006; 15(3): 172 - 178. [Abstract] [PDF]

				C.-D. Yang, K.-K. Hwang, W. Yan, K. Gallagher, J. FitzGerald, J. M. Grossman, B. H. Hahn, and P. P. Chen Identification of Anti-Plasmin Antibodies in the Antiphospholipid Syndrome That Inhibit Degradation of Fibrin J. Immunol., May 1, 2004; 172(9): 5765 - 5773. [Abstract] [Full Text] [PDF]

				W.-H. Chen, M.-Y. Lan, Y.-Y. Chang, S.-S. Chen, and J.-S. Liu The Prevalence of Protein C, Protein S, and Antithrombin III Deficiency in non-APS/SLE Chinese Adults with Noncardiac Cerebral Ischemia Clinical and Applied Thrombosis/Hemostasis, April 1, 2003; 9(2): 155 - 162. [Abstract] [PDF]

				T. E. Warkentin, W. C. Aird, and J. H. Rand Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome Hematology, January 1, 2003; 2003(1): 497 - 519. [Abstract] [Full Text] [PDF]